Product name and Generic name remains the Study name even after breaking the study
(Doc ID 1934059.1)
Last updated on JULY 13, 2023
Applies to:Oracle Life Sciences Argus Safety - Version 6.0.5 to 7.0.4 [Release 6.0 to 7.0.0]
Information in this document applies to any platform.
Case initially created with Report Type of "Sponsored Trial" where study was blinded.
After breaking the blinding, it was observed that the product name and generic name still reflected the study name rather than the actual product/generic name.
To view full details, sign in with your My Oracle Support account.
Don't have a My Oracle Support account? Click to get started!
In this Document